DG
Daniel Gannon
10% Owner

Daniel Gannon insider trades: Dnaprint Genomics (DNAG) stock purchases

10% Owner, Dnaprint Genomics Last trade Jan 6, 2009 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2008
1
Company
last trade 2009

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Daniel reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 6, 2009DNAG↑ Buy$391
Dec 31, 2008DNAG↑ Buy$345
Dec 26, 2008DNAG↑ Buy$2K
Dec 19, 2008DNAG↑ Buy$2K
Dec 12, 2008DNAG↑ Buy$2K
Dec 3, 2008DNAG↑ Buy$400
Nov 25, 2008DNAG↑ Buy$71
Nov 20, 2008DNAG↑ Buy$6K
Oct 31, 2008DNAG↑ Buy$15K
Oct 27, 2008DNAG↑ Buy$3K
Oct 10, 2008DNAG↑ Buy$5K
Oct 7, 2008DNAG↑ Buy$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Daniel Gannon's insider trades

Daniel Gannon is a 10% owner of Dnaprint Genomics (DNAG). Since Oct 7, 2008, Daniel has reported 12 open-market purchases worth $54K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNAG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.